Clinical Trial Update: Effects of YF476 and Rabeprazole on Gastric Function [Phase 1]

View source ↗

Summary

A Phase 1 trial assessed the effects of YF476 in combination with rabeprazole on gastric function in hypergastrinemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypergastrinemia

Drugs mentioned

• Rabeprazole (rabeprazole)
• YF476

Snippet

Sponsor: Trio Medicines Ltd. | Conditions: Hypergastrinaemia | Phase 1 | Status: COMPLETED